• Twitter
AMIVAS IRELAND LTD
  • ABOUT AMIVAS
    • GLOBAL GOALS
  • OUR PRODUCT
  • PARTNERING
  • NEWS
  • CAREERS
  • LIBRARY
  • CONTACT
  • Search
  • Menu Menu
You are here: Home1 / Press Releases
Press Releases

AMIVAS Ireland Ltd. Receives Authorisation from the Medicines & Healthcare Products Regulatory Agency (MHRA) to Market Artesunate Amivas (artesunate) in U.K. for Initial Treatment of Severe Malaria

13 June 2022
https://amivas.eu/wp-content/uploads/2021/12/amivas-logo-300x126.png 0 0 Admin https://amivas.eu/wp-content/uploads/2021/12/amivas-logo-300x126.png Admin2022-06-13 23:00:562022-06-13 10:43:48AMIVAS Ireland Ltd. Receives Authorisation from the Medicines & Healthcare Products Regulatory Agency (MHRA) to Market Artesunate Amivas (artesunate) in U.K. for Initial Treatment of Severe Malaria
Press Releases

Artesunate for Injection gains FDA Approval

0 Comments
/
27 May 2020
https://amivas.eu/wp-content/uploads/2021/12/amivas-logo-300x126.png 0 0 Admin https://amivas.eu/wp-content/uploads/2021/12/amivas-logo-300x126.png Admin2020-05-27 00:00:002020-05-27 12:41:37Artesunate for Injection gains FDA Approval

Pages

  • Amivas Ireland Ltd
  • Careers
  • Contact
  • Document Library
  • Global Goals
  • News
  • Our Product
  • Partnering

Categories

  • Press Releases

Archive

  • June 2022
  • May 2020
© 2021 Amivas Ireland Ltd. All rights reserved | Site by WordPress Hosting
  • Twitter
Scroll to top